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Abstract
Information on protein–protein interactions (PPIs) is of critical
importance for studying complex biological systems and develop-
ing therapeutic strategies. Here, we present a double-readout
bioluminescence-based two-hybrid technology, termed LuTHy,
which provides two quantitative scores in one experimental proce-
dure when testing binary interactions. PPIs are first monitored in
cells by quantification of bioluminescence resonance energy trans-
fer (BRET) and, following cell lysis, are again quantitatively
assessed by luminescence-based co-precipitation (LuC). The
double-readout procedure detects interactions with higher sensi-
tivity than traditional single-readout methods and is broadly appli-
cable, for example, for detecting the effects of small molecules or
disease-causing mutations on PPIs. Applying LuTHy in a focused
screen, we identified 42 interactions for the presynaptic chaperone
CSPa, causative to adult-onset neuronal ceroid lipofuscinosis
(ANCL), a progressive neurodegenerative disease. Nearly 50% of
PPIs were found to be affected when studying the effect of the
disease-causing missense mutations L115R and ΔL116 in CSPa with
LuTHy. Our study presents a robust, sensitive research tool with
high utility for investigating the molecular mechanisms by which
disease-associated mutations impair protein activity in biological
systems.
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Introduction
Protein–protein interactions (PPIs) play an essential role in the
proper functioning of living cells (Perkins et al, 2010; Cafarelli et al,
2017). They transmit information between signaling proteins, regu-
late enzymatic activities of proteins, and control the cellular tasks of
molecular machines (Couzens et al, 2013; Taipale et al, 2014;
Arumughan et al, 2016). Mutation-dependent perturbations of PPIs
play a crucial role in the development of diseases (Wang et al, 2012;
Sahni et al, 2015). The systematic identification and characteriza-
tion of interactions between human proteins is therefore of critical
importance to better understand complex biological processes and
molecular mechanisms of pathology (Stelzl et al, 2005; Bushell
et al, 2008; Markson et al, 2009; Rolland et al, 2014; Huttlin et al,
2017).
Several genetic methods for the identification of PPIs in
mammalian cells have been described (Buntru et al, 2016), includ-
ing mammalian protein–protein interaction trap (MAPPIT; Lievens
et al, 2016), fluorescence resonance energy transfer (FRET;
Gru¨nberg et al, 2013), single molecule pull-down (SiMPull; Jain
et al, 2011), dual luminescence-based co-precipitation (DULIP;
Trepte et al, 2015), avidity-based extracellular interaction screen
(AVEXIS; Bushell et al, 2008), or mammalian membrane two-
hybrid (MaMTH; Petschnigg et al, 2014), which all use different
biophysical principles and terminal readouts for PPI detection.
While in FRET-based assays, the association of proteins is moni-
tored directly through the energy transfer of tagged fluorescent
reporter proteins (Vogel et al, 2006), in MAPPIT or MaMTH, PPIs
are detected indirectly through auxiliary reactions of reporter
proteins (Petschnigg et al, 2014; Lievens et al, 2016). In some
methods, for example, MaMTH, interactions are detected in vivo
under steady state conditions, enabling the identification of tran-
sient and phosphorylation-dependent PPIs (Petschnigg et al, 2014).
In others, mammalian cells expressing tagged hybrid proteins are
lysed before binary interactions are detected in crude extracts. In
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DULIP or LUMIER (luminescence-based mammalian interactome
mapping), for example, PPIs are monitored by luminescence in co-
precipitations of protein complexes (Barrios-Rodiles et al, 2005;
Trepte et al, 2015). In contrast to MaMTH, these methods prefer-
ably detect PPIs with high binding affinities, while weak interac-
tions are less efficiently identified (Trepte et al, 2015). Due to this
diversity in procedures, underlying biophysical principles, and
detection readouts, it is not surprising that largely complementary
results are obtained when positive PPI reference sets are analyzed
systematically (Braun et al, 2009; Venkatesan et al, 2009; Chen
et al, 2010; Lievens et al, 2014). To create an improved technology
for more comprehensive and sensitive identification of PPIs than
currently possible, it seems advisable to combine different detec-
tion principles.
Here, we present LuTHy, a bioluminescence-based two-hybrid
method that enables the detection of binary PPIs with high sensitiv-
ity and specificity in mammalian cells through the combination of
two readouts in one experiment. Interactions between ProteinA-
mCitrine- and NanoLuc-tagged hybrid proteins are first detected
in vivo through quantification of BRET and subsequently ex vivo
through a luminescence-based co-precipitation (LuC). We bench-
marked LuTHy against known interactions and performed a targeted
screen to identify interactions of the synaptic protein CSPa, which
has a role in adult-onset neuronal ceroid lipofuscinosis (ANCL) and
other neurodegenerative disorders (Noskova´ et al, 2011; Sharma
et al, 2012; Burgoyne & Morgan, 2015). The disease relevance of




Our initial motivation in establishing LuTHy was to increase sensi-
tivity of PPI detection in order to generate datasets of higher confi-
dence and density than previously possible. To achieve this, we
developed a method that can detect both weak and strong as well as
direct and indirect PPIs in one procedure, using two different
biophysical detection principles.
Direct interactions between proteins of interest (X and Y) are
detectable in cells through quantification of bioluminescence reso-
nance energy transfer (BRET; Pfleger & Eidne, 2006), when the
tagged luciferase donors and fluorescent acceptors come into close
proximity (<10 nm; Dacres et al, 2012). We first constructed plas-
mids for the co-production of NanoLuc luciferase (NL) and
ProteinA-mCitrine (PA-mCit) hybrid fusion proteins in mammalian
cells to measure BRET (Fig 1A and Appendix Fig S1A and B). We
assumed that protein complex formation between NL-X and
PA-mCit-Y should subsequently be detectable in lysed cells with a
bioluminescence-based co-precipitation (LuC) assay (Fig 1A). Here,
the PA-tag in the hybrid protein is used for bait precipitation and
the NL-tag for the detection of the interacting prey (Fig 1A).
To prove our concept, we used the high-confidence interaction
BAD/BCL2L1, shown with several PPI detection assays (Braun et al,
2009; Trepte et al, 2015). Plasmids encoding the hybrid proteins
PA-mCit-BAD and NL-BCL2L1 as well as the control proteins PA-
mCit, NL, PA-NL, and PA-mCit-NL were generated (Fig 1B and
Dataset EV1), and recombinant protein production was confirmed
by SDS–PAGE and immunoblotting (Appendix Fig S1C–E).
We first assessed the interaction between BAD and BCL2L1
hybrid proteins with in-cell BRET measurements. We co-expressed
PA-mCit-BAD/NL-BCL2L1, PA-mCit-BAD/NL, PA-mCit/NL-BCL2L1,
and PA-mCit/NL in HEK293 cells and quantified luminescence
emission at 370–480 and 520–570 nm 48 h after transfection
(Appendix Fig S2). Emission was also quantified with the positive
control PA-mCit-NL and the control PA-NL, used to correct for
donor luminescence bleed-through (Pfleger et al, 2006). BRET ratios
were calculated (Appendix Fig S1F) and found to be significantly
higher in cells co-producing PA-mCit-BAD/NL-BCL2L1 compared to
the control interactions (Fig 1C), indicating that the BAD/BCL2L1
interaction can be detected through quantification of BRET. A high
BRET ratio was also obtained for PA-mCit-NL (Fig 1C), where NL
was directly linked to PA-mCit.
Next, we investigated PPI detection in LuC assays. We lysed the
transiently transfected cells directly after BRET measurement and
quantified fluorescence emission at 530 nm (mCitIN) as well as the
total luminescence emission after substrate addition (NLIN) in crude
protein extracts (Appendix Fig S3A), confirming the production of
PA-mCit- and NL-tagged proteins. We next precipitated the PA-
tagged proteins (PA-NL, PA-mCit, PA-mCit-BAD, and PA-mCit-NL)
from the lysates using IgG-coated 384-well microtiter plates. After
extensive washing, fluorescence (mCitOUT) and luminescence
(NLOUT) emission was quantified in the precipitated complexes
(Appendix Fig S3B). The luminescence signals obtained from crude
extracts and precipitates (Appendix Fig S3A and B) were used to
calculate normalized LuC ratios (Appendix Fig S1G) for all tested
binary interactions. LuC ratios are indicative of the co-precipitation
efficacy of NL-tagged prey proteins, which depends on expression
levels and the successful precipitation of PA-tagged baits. We found
a significantly higher LuC ratio for the interaction PA-mCit-BAD/NL-
BCL2L1 than for the controls (Fig 1D), confirming that it is specifi-
cally detected with the LuC readout. High LuC ratios were also
obtained for the hybrids PA-NL and PA-mCit-NL.
LuTHy detects binary interactions with high specificity
and sensitivity
To evaluate the performance of LuTHy more comprehensively, we
examined the previously established reference sets hPRS (Homo
sapiens positive) and hRRS (H. sapiens random; Braun et al, 2009),
containing 81 and 80 PPIs, respectively (Appendix Fig S4A and B).
Two expression plasmids were constructed for each protein to
produce both NL- and PA-mCit-tagged fusions, allowing analysis of
all proteins both as baits and preys.
In addition to potential interactions (NL-X/PA-mCit-Y), two
control interactions (NL-X/PA-mCit and NL/PA-mCit-Y) were tested
systematically, enabling calculation of corrected BRET (cBRET) and
LuC (cLuC) ratios (Appendix Fig S1F and G) for the entire reference
sets (Appendix Figs S4C and D, and S5A and B; Datasets EV2 and
EV3). We obtained cBRET and cLuC ratios for 303 binary interac-
tions from hPRS and hRRS, detecting PPIs with high reproducibility
in independent experiments with both readouts (Fig 2A and B),
indicating that LuTHy is suitable for larger scale screening. Receiver
operating characteristic (ROC) analysis was performed to define the
optimal cutoff for recovering positive interactions from hPRS
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(Fig 2C). “True” interactions in this PPI set were detected with
cutoffs of ≥ 0.01 and ≥ 0.03 for the cBRET and cLuC ratios, respec-
tively. Next, we also assessed whether the subcellular localization
of the tested interaction pairs influences the success rate of PPI
detection with LuTHy assays. Using the protein pairs in hPRS and
hRRS, we performed ROC analysis for known cytoplasmic, nuclear,
and membrane proteins to define the optimal cutoffs for PPI detec-
tion. We found that the initially defined cutoffs of ≥ 0.01 and ≥ 0.03
for cBRET and cLuC ratios, respectively, are well suited to define
“true” PPIs where at least one of the tested proteins per interaction
pair is a cytoplasmic, a nuclear, or a membrane protein
(Appendix Fig S5C–E). However, for protein pairs where both tested
proteins are known to be membrane-associated or contain
membrane-spanning domains more stringent cutoffs of ≥ 0.03
(cBRET) and ≥ 0.05 (cLuC) are required to define “true” interactions
(Appendix Fig S5F). Thus, using two cutoffs, 40 binary interactions
(49.4%) were finally recovered from hPRS, of which 36 (44.4%)
were identified with BRET, 22 (27.2%) with LuC and 18 (22.5%)
with both readouts (Fig 2D). When combining the results from both
readouts, LuTHy detects PPIs in hPRS with higher success rates than
KISS (Lievens et al, 2014), LUMIER (Barrios-Rodiles et al, 2005;
Braun et al, 2009), Y2H (Venkatesan et al, 2009; Chen et al, 2010),
and several other methods (Appendix Fig S6A and C), which have
success rates between 25 and 35% (Braun et al, 2009; Lievens et al,
2014). Compared to the older methods, LuTHy detected both new
and previously identified PPIs in hPRS, confirming that our
approach to combine two independent readouts (BRET and LuC) is
a valid strategy. Using the defined cutoffs, two interactions (2.5%)
were recovered from hRRS, none of which was double-positive
(0.0%), substantiating that the double-readout method detects PPIs
in reference sets with very high specificity and sensitivity
(Appendix Fig S6B and D).
A
B C D
Figure 1. The LuTHy procedure.
A Schematic representation of the workflow of the LuTHy method. Expression vectors encoding NL and PA-mCit-tagged hybrid proteins are cloned and co-transfected
into mammalian cells. Binary interactions are detected with a double readout; first, in vivo with in-cell bioluminescence resonance energy transfer (BRET) and second,
ex vivo with a luminescence-based co-precipitation (LuC).
B Schematic representation of control proteins and fusion proteins of interest for investigating the interaction between PA-mCit-BAD and NL-BCL2L1 in proof-of-
principle LuTHy experiments.
C Calculated BRET ratios for the indicated protein pairs. The positive control protein PA-mCit-NL and the interacting fusion proteins NL-BCL2L1 and PA-mCit-BAD show
high BRET ratios.
D Calculated LuC ratios for the indicated protein pairs. The positive control proteins PA-NL and PA-mCit-NL and the interacting proteins NL-BCL2L1 and PA-mCit-BAD
show high LuC ratios.
Data information: Data are representative of more than three independent experiments. All values are mean  s.d. Significance was calculated by one-way ANOVA
followed by Dunnett’s multiple comparisons post hoc test; ***P < 0.001.
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LuTHy detects low- and high-affinity interactions
To investigate whether LuTHy is able to detect interactions with dif-
ferent binding affinities (KDs), we next screened an affinity-based
interaction reference set, termed AIRS, including 71 interactions
with known KD values (Fig 3A and B and Dataset EV4). We
assessed each protein in AIRS both as bait and prey in two indepen-
dent experiments. Using the established cutoffs (Appendix Fig S5C–
F), we found that both BRET and LuC assays in LuTHy detected
AIRS PPIs with high reproducibility (Appendix Fig S7A and B).
LuTHy recovered 35 (49.3%) of 71 binary interactions
(Appendix Fig S7C), a similar success rate as with the hPRS
(Fig 2D). We identified 31 (43.7%) interactions with the BRET read-
out, 19 (26.8%) with LuC (Appendix Fig S7C–E), and 15 (21.1%)
with both, confirming the two components of LuTHy to yield
complementary but also overlapping results.
To assess the influence of interaction strength on the recovery of
PPIs, groups of interactions with low, medium, and high binding
affinities (Fig 3B) were analyzed. We found that in-cell BRET assays
detect strong and weak interactions with similar success rates
(Fig 3C), indicating binding-strength independence. LuC, in strong
contrast, recovered high-affinity interactions with significantly
higher success rates than low-affinity interactions (Fig 3C and D), as
previously observed for co-precipitation-based methods (Trepte
et al, 2015).
One of the high-affinity interactions (KD = 0.3 fM; Johnson et al,
2007) from AIRS, between the ribonuclease RNASE1 and its inhi-
bitor RNH1, is readily detectable with LuC but not with BRET
(Appendix Fig S8A–D). This supports binding affinity as the critical
parameter for detecting PPIs with LuC. With in-cell BRET, however,
resonance-energy-transfer efficiency critically depends on the prox-
imity and the orientation of donor and acceptor molecules (Dacres
et al, 2012). As FRET (Vogel et al, 2006) and DULIP (Trepte et al,
2015) assays are based on similar detection principles as the BRET
and LuC assays, respectively, we used them for the validation of this
specific interaction. While no significant FRET efficiency could be
measured (Appendix Fig S8E), we obtained high background-
corrected normalized luminescence-based interaction ratios (cNIRs)
using the DULIP assay (Appendix Fig S8F–H).
BRET50 ratios provide relative binding strengths for
binary interactions
Previous studies indicate that BRET assays can determine the rela-
tive binding strength between proteins when performed as donor
saturation assays, in which increasing acceptor/donor ratios are
A B
C D
Figure 2. Evaluation of assay performance with positive and negative binary reference sets.
A, B Reproducibility of LuTHy PPI mapping experiments with positive and negative reference sets. The scatter plots show the mean cBRET (A) and cLuC (B) ratios from
two independent experiments (Exp 1 and Exp 2), and the calculated two-tailed Pearson correlation coefficient is indicated; ***P < 0.001.
C Receiver operating characteristic (ROC) analysis of cBRET (AUC = 0.80  0.04) and cLuC (AUC = 0.72  0.04) data determines the thresholds to define true
positive binary interactions.
D Performance of BRET and LuC assays in benchmarking studies with hPRS and hRRS.
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systematically analyzed (Appendix Fig S9A; Drinovec et al, 2012;
Lavoie et al, 2013). We therefore produced saturation curves and
calculated BRET50 values with high reproducibility (Appendix Fig
S9B) for 25 of the 31 BRET-positive interactions in AIRS
(Appendix Fig S9C). Next, we plotted these values against published
KD values determined with cell-free biochemical methods (Wang
et al, 2004; Kastritis et al, 2011) and observed a highly significant
correlation between BRET50 and published KD values (Fig 3E). This
shows that BRET50 values are indeed indicative of protein binding
affinities and can provide valuable additional information about the
strengths of NL- and PA-mCit-tagged hybrid-protein interactions.
PPIs detected with LuTHy can be confirmed by fluorescence and
bioluminescence imaging (BLI)
In order to assess whether PPIs detected with LuTHy can be vali-
dated with imaging techniques, we examined the well-studied, func-
tional interaction between the synaptic proteins Syntaxin-1 and
Munc18 (Rizo & Su¨dhof, 2012), including the Munc18 variants with
single and double point mutations (K46E, E59K, and K46E/E59K).
K46E and E59K significantly reduce the binding affinity of Munc18
to Syntaxin-1; the double mutation even prevents the interaction
(Han et al, 2011). First, NL- and PA-mCit-tagged fusion protein
expression was confirmed by SDS–PAGE and immunoblotting
(Appendix Fig S10A). Systematic analysis with LuTHy revealed a
strong BRET signal for the PA-mCit-Syntaxin-1/NL-Munc18-WT
interaction, while lower BRET ratios were detected with NL-
Munc18-K46E and -E59K (Appendix Fig S10B). No interaction was
observed with the double mutant NL-Munc18-K46E/E59K, con-
firming published results (Han et al, 2011). Donor saturation curves
and BRET50 analysis confirmed the impact of the point mutations on
PPI detection (Appendix Fig S10C and D).
Finally, we assessed the influence of the mutations in Munc18 on
the subcellular localization of Syntaxin-1 with fluorescence micro-
scopy and BLI (Mezzanotte et al, 2017). Munc18 is critical for
targeting Syntaxin-1 to the plasma membrane in mammalian cells
(Han et al, 2011). We co-expressed PA-mCit-Syntaxin-1 with NL-
Munc18-WT, -K46E, -E59K, or -K46E/E59K in HEK293 cells and
A B
C D E
Figure 3. Systematic analysis of interacting proteins with known binding affinities.
A Selection of PPIs for the affinity-based interaction reference set (AIRS) from the PDBbind (Wang et al, 2004) and the Protein–Protein-Interaction Affinity Database 2.0
(Kastritis et al, 2011).
B Selected protein pairs cover a broad range of published binding affinities; PPIs with low (> 106 M), medium (> 108 M), and high binding affinities (≤ 108 M) were
sub-grouped in the AIRS.
C Recovery rates of PPIs from affinity-based sub-groups with BRET and LuC assays. Significance was calculated by two-sided Fisher’s exact test; *P < 0.05.
D Success of PPI detection from AIRS sub-groups considering single and double LuTHy readouts.
E Scatter plot depicting the relationships between published binding affinities (KD) and in-cell BRET50 measurements for 25 interactions in AIRS; BRET50 values are the
mean from two independent experiments. Significance was calculated by two-tailed Spearman correlation; ***P < 0.001.
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analyzed the Syntaxin-1 localization with fluorescence microscopy.
PA-mCit and PA-mCit-NL were investigated as controls. They were
distributed throughout the cytoplasm (Appendix Fig S10E), while
PA-mCit-Syntaxin-1 was predominantly located in the perinuclear
region in the absence of NL-Munc18-WT (Fig 4A). In its presence,
PA-mCit-Syntaxin-1 was targeted to the plasma membrane, con-
firming published reports (Han et al, 2011). Next, the NanoLuc
substrate was added and cells were assessed by BLI, with lumines-
cence emission recorded at 460 and 535 nm using appropriate band-
pass (BP) filters (Fig 4A and Appendix Fig S10E). Finally, BRET
images were calculated by dividing the intensities recorded at the
longer wavelength by those recorded at the shorter one. We
observed a strong BRET signal at the plasma membrane in cells co-
producing PA-mCit-Syntaxin-1 and NL-Munc18-WT, indicating a
direct interaction (Fig 4A). In comparison, BRET signals at the
plasma membrane were reduced or undetectable with the mutant
variants, confirming the initial BRET measurements in microtiter
plates (Appendix Fig S10B and C). Interestingly, in cells co-
producing NL-Munc18-K46E or -E59K, an accumulation of PA-mCit-
Syntaxin-1 in the perinuclear region was observed, probably
attributable to the loss of interaction at the plasma membrane.
Effects of chemical compounds and heat stress on
binary interactions
Targeting disease-relevant interactions with small molecules has
great potential for the development of new medicines, but discover-
ing drugs that potently and specifically stimulate or disrupt PPIs
remains a challenge (Scott et al, 2016). To assess whether LuTHy
can detect direct compound effects on PPIs, we first performed
proof-of-principle experiments with the well-known immunosup-
pressant rapamycin, which was previously shown to stimulate the
association of FKBP12 and the FRB domain of mTOR (Machleidt
et al, 2015). We incubated HEK293 cells co-producing NL-FKBP12
and PA-mCit-FRB with different concentrations of rapamycin and
quantified BRET and LuC ratios after 4 h. We observed a nanomolar,
concentration-dependent stimulation of the interaction with BRET
and LuC (Fig 4B), confirming earlier reports (Machleidt et al, 2015).
Next, we investigated the direct effect of Nutlin-3, an anti-cancer
agent previously shown to disrupt the association between MDM2
and the tumor suppressor p53 (Lievens et al, 2014), on the NL-
MDM2 and PA-mCit-p53 interaction. We incubated HEK293 cells
with different concentrations of Nutlin-3 and monitored the associa-
tion 6 h after compound addition. We observed that the compound
potently inhibited (IC50 ~8 and 11 nM) the interaction in mamma-
lian cells (Fig 4C), confirming previously published results (Lievens
et al, 2014).
We hypothesized that besides direct also indirect compound
effects on PPIs should be detectable with the LuTHy technology.
To address this question, we next investigated the effects of the
small molecules ganetespib and geldanamycin on the self-associa-
tion of heat shock factor 1 (HSF1) in mammalian cells. This
protein is known to trimerize under heat stress conditions, lead-
ing to transcriptional activation of heat shock genes, such as
HSP70 and HSP40 (Morimoto, 1993; Gil et al, 2017). Further-
more, previous studies have demonstrated that a cellular
response similar to a heat shock can be induced upon treatment
of cells with the Hsp90 inhibitors ganetespib and geldanamycin
(Stebbins et al, 1997; Lin et al, 2008), suggesting that these
compounds might indirectly influence HSF1 oligomerization. To
address this, we co-expressed NL-HSF1 and PA-mCit-HSF1 in
HEK293 cells and, 24 h post-transfection, treated the cells with
the chemical compounds ganetespib and geldanamycin. BRET
ratios were quantified after 1, 3, 6, 12, 18, 24, and 48 h in
compound-treated and untreated cells. In comparison with
untreated cells, we observed a significant increase in the BRET
signal after 3 h in compound-treated cells, which slowly
decreased over time (Fig 4D), indicating that both compounds
indirectly stimulate the self-association of HSF1.
Finally, we assessed whether heat shock conditions also stimu-
late the association of HSF1 in mammalian cells (Rabindran et al,
1993). We exposed HEK293 cells co-expressing the proteins NL-
HSF1 and PA-mCit-HSF1 to heat shock (42°C) and monitored the
association of the fusion proteins by quantification of BRET after 90,
180, or 360 min. In addition, BRET was quantified in cells before
the heat shock and after a recovery phase of 18 h at 37°C. We
observed a rapid increase of the BRET signal upon heat stimulation,
which decreased again to normal levels during the recovery phase
at 37°C (Fig 4E). Thus, the impact of heat stress on PPIs can be
readily monitored using the LuTHy method.
▸Figure 4. Effects of missense mutations and small molecules on PPI detection with LuTHy.A Live-cell bioluminescence imaging (BLI) of HEK293 cells co-producing the indicated fusion proteins. mCitrine was excited at 500 nm, and emitted fluorescence was
detected at 535 nm. After substrate addition, short (460) and long (535) band-pass (BP) filters in a dual-view adapter were used to detect the emitted luminescence
simultaneously at the respective wavelengths. BRET images were calculated by dividing the 535 BP by the 460 BP images using ImageJ. Scale bar = 20 lm.
B Quantification of the rapamycin-induced interaction between NL-FKBP12 and PA-mCit-FRB. Plasmids encoding the fusion proteins were co-transfected in HEK293
cells and 24 h later treated with the indicated concentrations of rapamycin. After an additional incubation for 4 h, BRET was quantified upon substrate addition.
After cell lysis in buffer with indicated rapamycin concentrations, LuC ratios were determined. EC50 values were obtained with nonlinear curve fitting. Data are
representative of at least two independent experiments. All values are mean  s.d.
C Effects of Nutlin-3 on the interaction between NL-MDM2 and PA-mCit-p53. Same procedure as in (B) except for 6 h treatment with Nutlin-3. Data are representative
of at least two independent experiments. All values are mean  s.d.
D Time resolved HSF1 oligomerization by Hsp90 inhibition. HEK293 cells co-producing NL-HSF1 and PA-mCit-HSF1 for 24 h were transferred to 384-well plates
containing ganetespib or geldanamycin to reach a final concentration of 1 lM. Luminescence was measured at the indicated time points and the calculated BRET
ratios normalized to the respective untreated control. Data are the mean of two biological replicates. All values are mean  s.e.m. Significance was calculated by
two-way ANOVA followed by Dunnett’s multiple comparison’s post hoc test. *P < 0.05; **P < 0.005; ***P < 0.001.
E Schematic depiction of a heat shock experiment. HEK293 cells co-producing NL-HSF1/PA-mCit-HSF1 for 48 h were subjected to a heat shock at 42°C for 6 h, after
which the cells were recovered at 37°C for 24 h. Luminescence was measured at the indicated time points: immediately before the heat shock, during the heat shock
at 90, 180, and 360 min, and after a recovery phase of 24 h. Calculated cBRET ratios were normalized to a control plate that was not heat-treated. All values are
mean  s.e.m. from three independent experiments. Significance was calculated by one-way ANOVA followed by Dunnett’s multiple comparisons post hoc test;
*P < 0.05.
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The positioning of fusion tags in hybrid proteins influences the
success rate of PPI detection
Previous studies indicate that the positioning of fusion tags either at
the N- or C-terminus of proteins of interest influences the success of
PPI detection with two-hybrid methods (Stellberger et al, 2010). To
address this question systematically, we generated expression plas-
mids to produce the protein VCP (valosin-containing protein) and
10 ubiquitin regulator X (UBX) domain-containing proteins (p37,
p47, UBXD1-6, UBXD8, and UBXD9) as N- and C-terminally tagged
NL- and PA-mCit-fusions in mammalian cells (Fig 5A, and Datasets
EV1 and EV5). Previously, interactions between VCP and all of these
10 UBX-domain-containing proteins have been reported (Raman
et al, 2015), suggesting that they should also be detectable with the
LuTHy technology. We systematically tested each interaction (e.g.,
between VCP and p37) in the eight possible hybrid-protein combina-
tions, determining cBRET and cLuC ratios for 80 PPIs in HEK293




Figure 5. Systematic investigation of the impact of fusion-tag orientation.
A Domain overview of VCP and 10 UBX-domain-containing proteins. The UBX proteins bind with their C-terminally located UBX-domains to the N-domain in VCP,
with the exception of UBXD1 that binds to the C-terminus of VCP via a PUB domain.
B, C VCP and the UBX-domain-containing proteins were co-expressed as N- and C-terminal NL and PA-mCit fusion proteins in eight different orientations for which
cBRET (B) and cLuC (C) ratios were generated. cBRET and cLuC values over the threshold of ≥ 0.01 and ≥ 0.03, respectively, are colored in cyan.
D The cBRET and cLuC ratios were normalized to the highest of the obtained eight values to easily identify the orientation among the eight tested interactions with
the highest cBRET and cLuC value.
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and LuC measurements in LuTHy assays (Fig 5B and C), confirming
the previous results (Raman et al, 2015). However, it is important
to note that the success of PPI detection with both readouts is influ-
enced by the site of tagging (Dataset EV5). We found that 46
(57.5%) and 41 (51.3%) of the 80 tested binary interactions scored
positive in BRET and LuC assays, respectively, indicating that multi-
ple combinations of hybrid proteins reveal positive PPIs in system-
atic LuTHy experiments.
It is known that UBX proteins bind with their C-terminal UBX-
domain to the N-domain of VCP (Fig 5A). Accordingly, the highest
cBRET ratios were obtained when VCP was tagged at its N-
terminus and the UBX proteins at their C-terminus, respectively
(Fig 5D). Exceptions were UBXD1, which binds to the C-terminus
of VCP and UBXD9, which is known to remodel VCP into a
heterotetrameric structure (Arumughan et al, 2016). This suggests
that for BRET experiments, fusion tags should be added in close
proximity to the interaction domain. In contrast, the LuC results
showed no clear preference for fusion-tag orientation. However, it
seems that the highest cLuC ratios are obtained when VCP was
used as the bait (Fig 5D), indicating that it is crucial for PPI detec-
tion with LuC, which of the two proteins of interest contains the
PA-tag.
Finally, we investigated whether the LuTHy technology also
detects PPIs when the hybrid proteins are expressed in cells at simi-
lar-to-endogenous protein levels. To address this question, we
focused on the interaction between VCP and UBXD9 that was
repeatedly detected in BRET and LuC assays (Fig 5B–D). We first
performed transfection experiments with different concentrations of
plasmid DNA and determined that concentrations of 1 and 25 ng of
the plasmids pcDNA3.1-NL-VCP and -UBXD9-mCit, respectively, are
sufficient to detect luminescence and fluorescence activities in
HEK293 cells (Appendix Fig S11A and B). Analysis of cell extracts
by SDS–PAGE and immunoblotting revealed that under these experi-
mental conditions, the recombinant proteins are expressed at
endogenous protein levels or even below (Appendix Fig S11C and
D). Next, we co-transfected the plasmids into HEK293 cells (1 and
25 ng) and assessed their association by quantification of BRET. In
comparison with control interactions (NL-VCP/mCit or UBXD9-
mCit/NL), we detected a significant BRET signal in NL-VCP/UBXD9-
mCit co-expressing cells (Appendix Fig S11E), indicating that the
LuTHy technology detects PPIs, even when the hybrid proteins are
expressed at very low levels in cells.
Identification of CSPa-interaction partners
To assess whether LuTHy can be applied for systematic protein
interaction screening, we generated a target library of expression
plasmids encoding 125 NL-tagged presynaptic proteins that play a
functional role in synaptic transmission. We selected various
components of the exocytosis/endocytosis machinery as well as
regulators of this process (Appendix Fig S12A and Dataset EV6). In
addition, we created a plasmid for the expression of PA-mCit-tagged
CSPa, a molecular chaperone in the synapse (Sharma et al, 2011).
CSPa maintains protein homeostasis in the presynapse and likely
associates with multiple proteins that play a role in synaptic trans-
mission (Zhang et al, 2012; Donnelier & Braun, 2014). To this day,
however, only a few direct binding partners such as SNAP25 or
dynamin-1 have been identified (Sharma et al, 2011; Zhang et al,
2012), suggesting that additional PPIs can be found by targeted
interaction screening.
Using the established cutoffs, we systematically screened 125
protein pairs in two independent experiments (Appendix Fig S12B
and C), identifying a total of 42 interactions with CSPa-mCit-PA
(Fig 6A, Appendix Fig S13A and B and Dataset EV6); 36 PPIs were
identified with the BRET and seven with the LuC readout
(Appendix Fig S13A and B and Dataset EV6). Three (7.1%) of the
42 identified PPIs were already known (Dataset EV7), while over
90% of PPIs detected with LuTHy have not been reported. A large
fraction of the detected interactors are SNARE complex members
and proteins involved in vesicle fusion processes (Dataset EV8),
confirming a functional role of CSPa in synaptic vesicle exocytosis
(Sharma et al, 2011).
Our analysis revealed that a relatively large fraction (22 of 42,
52%) of the identified CSPa interaction partners are membrane-
associated or membrane domain-containing proteins (Appendix Fig
S14A, and Datasets EV6 and EV8). This is not unexpected due to the
fact that CSPa in cells gets palmitoylated (Greaves et al, 2012) and
probably is attached to membranes, when it interacts with NL-
tagged partner proteins. To assess whether CSPa interacts specifi-
cally with membrane proteins, we performed an additional focused
PPI screen with the protein PICK1 (Thomas et al, 2013), which,
similar to CSPa, is palmitoylated in cells and attaches to membranes
(Appendix Fig S14B). Quantification of cBRET and cLuC ratios con-
firmed the interactions between CSPa-mCit-PA and the 22 tested
NL-tagged membrane-associated or membrane domain-containing
proteins (Appendix Fig S14C and D, Dataset EV9). In contrast, no or
very weak interactions were detected with PICK1, substantiating our
result that CSPa interacts specifically with membrane proteins.
Finally, we investigated whether the interactions between CSPa
and membrane-associated or membrane domain-containing proteins
can be also detected in primary hippocampal neurons under endoge-
nous conditions. We selected five positive and one negative interac-
tion from the PPI dataset and performed in situ proximity ligation
assays (PLAs) using target-specific antibodies. With this approach,
all LuTHy positive PPIs such as the association of CSPa with
SLC17A7, SYP, or SYT1 were confirmed in neuronal cells, while the
LuTHy negative interaction with STX4 could not be detected
(Appendix Fig S14E). This indicates that biologically relevant
interactions with membrane proteins are identified with the LuTHy
technology.
CSPa preferentially associates with synaptic proteins
The relatively high success rate of PPI detection (42 of 125, 34%) in
our initial interaction screen suggests that CSPa preferentially inter-
acts with synaptic proteins involved in endo-/exocytotic processes
(Dataset EV6). As confirmation, we performed an additional interac-
tion screen with CSPa-mCit-PA and a target library of 131 mostly
non-synaptic NL-tagged proteins. With this protein set, we identified
a total of 18 PPIs (14%), of which 12 interactions were identified
with the BRET and eight with the LuC readout (Appendix Fig S14F,
Dataset EV10). Interestingly, the success rate of PPI detection with
CSPa was significantly lower among non-synaptic than among
synaptic proteins (Appendix Fig S14G), supporting our hypothesis
that CSPa has a preference of interacting with synaptic proteins.
This is in agreement with previous observations that CSPa is a
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presynaptic co-chaperone that is critical for synapse maintenance
(Sharma et al, 2011).
Finally, our analysis revealed that six of the 18 (33%) identified
CSPa-interacting proteins in the non-synaptic protein set are
membrane-associated or contain membrane-spanning domains
(Appendix Fig S14H), suggesting that the chaperone has a bias for
such proteins. However, statistical analysis revealed that CSPa has
no significant preference for interacting with membrane or
membrane-associated proteins in both tested protein stets (synaptic
and non-synaptic; Appendix Fig S14H).
Disease-causing mutations influence the association of CSPa
with partner proteins
Two mutations in CSPa (DL116 and L115R, Fig 6A) cause adult-
onset neuronal ceroid lipofuscinosis (ANCL), a rare neurological
disease characterized by dementia and impairment of muscle coor-
dination (Josephson et al, 2001; Noskova´ et al, 2011). To address
whether these mutations influence the association of CSPa with
partner proteins, we tested whether the mutant fusion proteins
CSPa(DL116)-mCit-PA and CSPa(L115R)-mCit-PA show altered
interactions with NL-tagged partner proteins in comparison with
wild-type CSPa-mCit-PA. Interactions with the mutant variants in
comparison with wild-type CSPa showed many altered cBRET and
cLuC ratios (Fig 6B and C, Appendix Fig S15A and B and Dataset
EV11), indicating that the mutations influence CSPa PPIs. In
general, more interactions with membrane proteins were affected
than with non-membrane proteins (Appendix Fig S15C) and in most
cases the cBRET or the cLuC signals for membrane proteins were
decreased (11 of 13, 85%). In comparison, many non-membrane
proteins showed enhanced binding to the mutant variants of CSPa




Figure 6. Disease-causing mutations influence the association of CSPa with partner proteins.
A Overview of the targeted PPI screen. CSPa-mCit-PA was screened in two independent experiments against a focused library of 125 NL-tagged presynaptic proteins.
Venn diagram depicting the 42 identified CSPa interaction partners. Domain structure of CSPa. The J-domain and the cysteine-string domain (CSD) are depicted.
The ANCL-causing mutations DL116 and L115R are indicated.
B, C Tukey box plots of the mean cBRET (B) and cLuC ratios (C) obtained from two independent PPI experiments with wild-type CSPa-mCit-PA and its mutant variants.
Significance was calculated by one-way ANOVA followed by Dunnett’s multiple comparisons post hoc test. *P < 0.05.
D Number of screened presynaptic proteins manually annotated according to their function and localization in the presynaptic terminal. Number of proteins
identified with wild-type (wt) CSPa-mCit-PA or its mutant variants (DL116 and L115R) are indicated.
E Influence of mutations in CSPa (DL116, L115R) on the interactions with ZDHHC17 in primary hippocampal neurons. BRET and LuC ratios were systematically
quantified for interactions with wild-type and mutant CSPa fusion proteins. Data are representative of three independent experiments. All values are mean  s.d.
Significance was calculated by two-way ANOVA followed by Dunnett’s multiple comparisons post hoc test; **P < 0.005; ***P < 0.001.
F Immunoblot analysis of SHEP cells transfected with plasmids encoding wild-type CSPa-mCit-PA and mutant variants. Blot was developed with an anti-CSP
antibody; loading control: anti-Histone-H3 antibody. Arrowhead and bracket indicate monomeric CSPa-mCit-PA and SDS-insoluble protein aggregates, respectively.
G Immunofluorescence image of SHEP cells co-transfected with NL-ZDHHC17 and CSPa-mCit-wt, -DL116 or -L115R constructs lacking the PA-tag. NL-ZDHHC17 was
stained with an anti-NanoLuc antibody. Scale bar: 20 lm.
10 of 20 Molecular Systems Biology 14: e8071 | 2018 ª 2018 The Authors
Molecular Systems Biology Bioluminescence-based two-hybrid mapping Philipp Trepte et al
Published online: July 11, 2018 
To validate the impact of the mutations on PPIs exemplarily, we
performed donor saturation assays with synaptotagmin-1 (SYT1), a
calcium sensor for neurotransmitter release (Su¨dhof & Rizo, 2011).
Significantly higher BRET50 values were obtained with the mutant
variants of CSPa compared to the wild-type control protein
(Appendix Fig S15D and E), confirming weaker binding to SYT1. In
addition to SYT1, many proteins involved in vesicle fusion and
neurotransmitter release (LIN7A, SCAMP1, STX3, SYP, SYT5,
VAMP2-4) showed altered binding to mutant CSPa, suggesting that
the disease-causing mutations might influence synaptic transmission
in brains of ANCL patients. Using LuTHy, we found that ~50% of all
interactions detected with wild-type CSPa-mCit-PA are disturbed by
the two disease mutations (Fig 6D and Dataset EV11).
The disease-causing mutations DL116 and L115R promote
the association between CSPa and the
palmitoyltransferase ZDHHC17
Using LuTHy, a strong interaction between CSPa and the palmitoyl-
transferase ZDHHC17 was detected with both BRET and LuC read-
outs, confirming previously published results (Greaves et al, 2012).
Palmitoylation of CSPa in presynaptic terminals was reported to be
critical for normal protein function (Lopez-Ortega et al, 2017). It
occurs in a cysteine-string domain (Fig 6A), which is altered in its
amino acid sequence by the disease-causing mutations DL116 and
L115R, suggesting they might influence palmitoylation efficiency
and/or the interaction with the palmitoylating enzymes. We found
that the disease-causing mutations promote the association between
CSPa and ZDHHC17 (Appendix Fig S15A and B), a result that was
also confirmed in independent experiments by applying LuTHy in
primary hippocampal neurons showing significantly increased
cBRET and cLuC ratios with the mutant variants compared to wild-
type CSPa (Fig 6E).
SDS–PAGE and immunoblotting of the tagged mutant CSPa
fusions revealed that SDS-stable, high-molecular-weight species are
detectable in cell lysates besides soluble protein migrating at
~63 kDa (Fig 6F). Such structures were not observed in cells
expressing wild-type CSPa-mCit-PA, indicating that at least a frac-
tion of the mutant fusion proteins is abnormally aggregated in
mammalian cells. The formation of protein aggregates in the peri-
nuclear region was confirmed by immunofluorescence microscopy
(Fig 6G). Furthermore, we observed co-localization of ZDHHC17
with CSPa DL116 and L115R aggregates in cells, suggesting that the
stronger interactions observed with mutant CSPa proteins in BRET
and LuC assays are caused by protein co-aggregation. This view is
supported by recent observations that disease-associated aggregates
can recruit a variety of cellular proteins and promote their co-
assembly into higher molecular weight structures (Kim et al, 2016).
Discussion
LuTHy is a new double-readout bioluminescence-based two-hybrid
method for systematic protein interaction mapping. Performing in-
cell BRET, followed by a cell lysis step and an ex vivo luminescence
co-precipitation assay with crude protein extract (Fig 1A), it was
possible for the first time to obtain two quantitative measurements
for tested protein pairs in one procedure. PPIs detected with two
readouts provide more information, are potentially of higher confi-
dence, and require less further validation (Braun et al, 2009) than
PPIs identified with only one readout. In contrast to earlier methods
(Trepte et al, 2015), LuTHy, with its BRET component, identifies
low-affinity interactions before cell lysis, circumventing disruption
of weak interactions that only occur in the intact cellular environ-
ment. In this way, LuTHy increases sensitivity and coverage consid-
erably. Benchmarking the method with well-defined reference sets
(Braun et al, 2009; Venkatesan et al, 2009), we found similar repro-
ducibility and specificity than with previously reported single-
readout methods. With a sensitivity of ~50% (Fig 2D); however,
LuTHy outperforms single-readout methods like MAPPIT or
LUMIER that only detect ~35% of PPIs (Braun et al, 2009).
Positive BRET suggests direct binding, as interactors need to
come into close proximity (Pfleger & Eidne, 2006). LuC, like all
precipitation approaches, does not exclude the possibility that bridg-
ing proteins mediate complex formation (De Las Rivas & Fontanillo,
2010) and exhibits a preference for high-affinity PPIs (Fig 3C). Inter-
acting proteins detected with both readouts are likely to associate
directly and strongly. However, it is important to note that potential
false-positive LuTHy results could emerge from crowding effects
due to high hybrid-protein expression or when both tagged proteins
of interest are targeted to membrane surfaces. To circumvent this,
we generally use low plasmid DNA concentrations to produce
recombinant proteins in cells (Appendix Fig S11) and have also
implemented a more stringent cutoff specifically for the investiga-
tion of membrane protein interactions (Appendix Fig S5F).
Quantitative PPI maps have recently been created using LUMIER
with BACON (Taipale et al, 2012), revealing functional chaperone
complexes and cellular proteostasis pathways (Taipale et al, 2014).
Through its double readout, LuTHy should strongly advance hierar-
chical clustering and improve the predictions of functional protein
modules (Braun et al, 2009).
For validation and also upscaling, we performed targeted PPI
screens with libraries of > 120 synaptic or non-synaptic control
proteins against the presynaptic chaperone CSPa (Donnelier &
Braun, 2014). Identification of 42 synaptic proteins, with > 90% not
yet described as CSPa partners, indicates that only few of the CSPa-
interacting proteins in the presynapse are currently known and con-
firms the protein’s functional role in various synaptic processes
(Su¨dhof & Rizo, 2011).
LuTHy is also highly powerful to detect stimulating and disrupt-
ing effects of chemical compounds or external stimuli on interac-
tions. It may be a valuable tool to address this challenging area in
drug discovery. Arrays of binary interactions, for example, for speci-
fic signaling cascades like MAPK (Bandyopadhyay et al, 2010) or
ErbB (Petschnigg et al, 2014), could be used as quantitative sensors
for systematic drug profiling with LuTHy.
Likewise, LuTHy facilitates improved characterization of disease-
associated mutations, providing reliable data on increased as well as
decreased binding of proteins when mutated. The impact of
missense mutations has been systematically assessed with Y2H or
LUMIER, with ~60% found to perturb PPIs and ~30% to cause
complete loss of interactions (Sahni et al, 2015). Quantitative
assessment with LuTHy for the disease mutations in CSPa con-
firmed this observation (Fig 6D).
Besides its potential to increase coverage and quality, LuTHy can
be used in the future to study the dynamics of interactions induced
ª 2018 The Authors Molecular Systems Biology 14: e8071 | 2018 11 of 20
Philipp Trepte et al Bioluminescence-based two-hybrid mapping Molecular Systems Biology
Published online: July 11, 2018 
by specific stimuli in mammalian cells. Finally, it has an application
in investigating the impact of posttranslational modifications on
PPIs and signaling cascades.
In summary, LuTHy is a powerful method for improved, quan-
titative interactomics studies. Calculation of dimensionless BRET/
LuC ratios improves comparability between labs, a challenge for
all binary PPI detection methods to date. LuTHy detects PPIs
without a bias for or against specific protein classes and is trans-
ferrable to a variety of cell lines. Greater depth of information
per interaction in shorter time and amenability to automation will
make large-scale screening campaigns considerably more time-
and cost-efficient.
Materials and Methods
Reagents and Tools table
Reagent/resource Reference or source Identifier or catalog number
Experimental models
HEK-293 cells (H. sapiens) ATCC CRL-1573
SHEP cells (H. sapiens) Muth et al (2010) (Cancer Research) Prof. Dr. Manfred Schwab, DKFZ, Germany
C57BL6/J (M. musculus) Charles River/JAXTM N/A
C57BL6/J (M. musculus) FEM Charité N/A
Recombinant DNA
pmTq2-DEVD-mCit Grünberg et al (2013) N/A
FR-20-Che~Sp1 Grünberg et al (2013) N/A
FK-20-Cit(K)-WW Grünberg et al (2013) N/A
pPA-RL-GW Trepte et al (2015) N/A
pGW-RL-PA Trepte et al (2015) N/A





pCMV-SPORT6-DNAJC5 Open Biosystems EHS1001-737176
pDONR223-SYT1 The CCSB Human Orfeome Collection 12023
pDONR223-RNASE1 The CCSB Human Orfeome Collection 5532
pDONR223-RNH1 The CCSB Human Orfeome Collection 3255
pDONR221-mCherry Trepte et al (2015) N/A
pDONR221-Munc18 wt Trepte et al (2015) N/A
pDONR221-Munc18 K46E Trepte et al (2015) N/A
pDONR221-Munc18 E59K Trepte et al (2015) N/A
pDONR221-Munc18 K46E/E59K Trepte et al (2015) N/A
pDS_X-mCherry ATCC MBA-303
pDONR221-NL This study N/A
pDONR221-FRB This study N/A
pDONR221-FKBP12 This study N/A
pDONR221-DNAJC5 This study N/A
pDONR221-SYT1DTM This study N/A
pDONR221-VCP This study N/A
pPA-mCit-mChe This study N/A
Additional plasmids and more information This study Dataset EV1
Antibodies
Sheep gamma globulin Jackson ImmunoResearch 013-000-002
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Reagents and Tools table (continued)
Reagent/resource Reference or source Identifier or catalog number
Rabbit anti-sheep IgGs Jackson ImmunoResearch 313-005-003
Goat anti-rabbit HRP Sigma A0545
Goat anti-mouse HRP Sigma A0168
Rabbit anti-NanoLuc Promega N/A
Rabbit anti-GFP Abcam ab290
Rabbit anti-CSPa Synaptic Systems 154 003
Rabbit anti-H3 Abcam ab1791
Mouse anti-VCP Progen 65278
Rabbit anti-UBXD9 LifeSpan Biosciences LS-C156546/EPR8616
Mouse anti-tubulin Sigma T6074
Mouse anti-VGLUT1 Synaptic Systems 135 311
Mouse anti-VGAT Synaptic Systems 131 011
Mouse anti-STX4 Synaptic Systems 110 041
Mouse anti-SYP Sigma SVP-38
Mouse anti-SYT1 SantaCruz sc-135574
Mouse anti-VAMP2 Synaptic Systems 104 211
Mouse IgG control ThermoFisher 02-6502
Oligonucleotides and sequence-based reagents
PCR primers This study Dataset EV12
Chemicals, enzymes and other reagents
Phusion High-Fidelity DNA Polymerase ThermoFisher F530L
GatewayTM LR ClonaseTM II Enzyme mix ThermoFisher 11791100
DMEM low glucose ThermoFisher 31885049
DMEM high glucose ThermoFisher 41965062
DMEM high glucose, HEPES, no phenol red ThermoFisher 21063029
Fetal bovine serum (FBS) ThermoFisher 10270106
Linear polyethylenimine (PEI), 25 kDa Polysciences 23966-2
Cell culture microplate, 96-well white Greiner 655983











NuPAGETM NOVEXTM 4-12% Bis-Tris ThermoFisher NP0323BOX
Nitrocellulose membrane GE Healthcare 10401197
WesternBright Quantum Advansta 12042-D20
ibidi® l-Slide 8-well ibidi 80827
X-tremeGENE 9 Sigma-Aldrich 000000006365779001
Duolink® In Situ Detection Reagents Orange Sigma-Aldrich DUO92007
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Reagents and Tools table (continued)
Reagent/resource Reference or source Identifier or catalog number
GeneJetTM SignaGen SL100488
PierceTM BCA Protein assay ThermoFisher 23225
Software




Tecan Infinite M200 Tecan
Tecan Infinite M1000 Tecan
Tecan Infinite M1000Pro Tecan
Tecan Infinite Spark Tecan
Fujifilm LAS-3000 Fujufilm
Olympus IX83 with Andor Zyla camera and Dual-ViewTM adapter Olympus, Andor and Optical Insights
Methods and Protocols
Plasmid construction
Destination vectors encoding N- and C-terminally tagged fusion
proteins were generated based on the pcDNA3.1 (+) vector (Invit-
rogen). For the acceptor vectors pcDNA3.1-PA-mCit-GW,
pcDNA3.1-GW-mCit-PA, and pcDNA3.1-PA-mCit, the coding
sequences for mCitrine (mCit) and ProteinA (PA) were amplified
from pmTq2-DEVD-mCit (kindly provided by Dr. Raik Gru¨nberg,
Center for Genomic Regulation, Barcelona) and pPA-RL-GW
(Trepte et al, 2015), respectively. For N-terminal fusions, cDNAs
encoding PA and mCit were amplified using the primers #1, to #4,
respectively. For generation of plasmids encoding C-terminal
fusions, cDNA fragments encoding PA and mCit were amplified
using the primers #5 and #6 as well as #7 and #8, respectively.
For the control vector pPA-mCit, which contains a stop codon after
the mCit coding sequence, the primers #1 and #2 were used to
amplify the PA-tag and the primers #3 and #9 to amplify the mCit
tag. For the donor vectors pcDNA3.1-NL-GW, pcDNA3.1-GW-NL,
and pcDNA3.1-NL, the NanoLuc coding sequence was amplified
from pNL1.1 (Promega). For plasmids encoding N-terminal and C-
terminal fusions, cDNAs were amplified using the primers #10 and
#11 as well as #12 and #13, respectively. For the control vector
pNL, the primers #10 and #14 were used to amplify a fragment
encoding cmyc-NanoLuc. For all destination vectors, the resulting
PCR fragments were cloned into pcDNA3.1 (+) (Invitrogen) via
NheI/EcoRI/HindIII restriction sites. For control vectors and N- or
C-terminal fusion vectors, the restriction sites EcoRI/XhoI/HindIII
were used. Subsequently, the Gateway cassette was amplified from
pGW-RL-PA (Trepte et al, 2015) to generate the N-terminal fusion
vectors pcDNA3.1-PA-mCit-GW and pcDNA3.1-NL-GW using the
primers #15 and #16. Similarly, for the creation of C-terminal
fusions vectors pcDNA3.1-GW-mCit-PA and pcDNA3.1-GW-NL the
primers #17 and #18 were utilized. The resulting PCR fragments
encoding the Gateway cassette were cloned in the generated
vectors containing the PA-mCit or NL coding sequences. For the
N-terminal fusion vectors, the restriction sites HindIII/XhoI, and
for the C-terminal fusion vectors, the restriction sites NheI/HindIII
were used. To generate the vector pcDNA3.1-PA-NL, the cDNA
encoding the PA-tag was amplified using the primers #19 and #20;
the cDNA fragment encoding NanoLuc was amplified using the
primers #21 and #22. The resulting PCR products were cloned
simultaneously in pcDNA3.1 (+) (Invitrogen) via the restriction
sites NheI/EcoRI/HindIII. The vector pmCherryGW (Invitrogen)
was digested using the restriction sites XhoI and SgrAI. Then, it
was ligated with the self-annealed primer #23 to obtain the plas-
mid pmCherry lacking the Gateway cassette. Lentiviral LuTHy
plasmids were generated by the Viral Core Facility (Charite´,
Universita¨tsmedizin Berlin, Germany) based on the FUGW plasmid
(FUGW was a gift from David Baltimore, Addgene plasmid
#14883). The respective reporter genes and Gateway cassettes were
cloned from the pcDNA3.1-based LuTHy vectors to generate pLenti
PA-mCit-GW, pLenti-GW-mCit-PA, pLenti-NL-GW, and pLenti-GW-
NL.
To generate the entry plasmids pDONR221-NL, pDONR221-FRB,
pDONR221-FKBP12, pDONR221-DNAJC5 (CSPa) pDONR221-
SYT1DTM, and pDONR221-VCP the sequences encoding the
proteins of interest were PCR amplified and the resulting fragments
were shuttled into pDONR221 (Invitrogen) using the BP clonase
(Invitrogen). The cDNA encoding NanoLuc was amplified using the
primers #24 and #25 from vector pNL1.1 (Promega). The FRB frag-
ment encoding the amino acids 2,021–2,113aa of mTOR was ampli-
fied using the primers #26 and #27 from the vector FR-20-Che~Sp1.
FKBP12 was amplified using the primers #28 and #29 from the
vector FK-20-Cit(K)-WW, which was kindly provided by Dr. Raik
Gru¨nberg (Center for Genomic Regulation, Barcelona). The coding
sequence of CSPa/DNAJC5 was amplified using the primers #30 and
#31 from the pCMV-SPORT6-DNAJC5 vector (Open Biosystems,
EHS1001-7373176). To create the SYT1, the entry plasmid lacking
the vesicular and transmembrane domain, base pairs 241–1,266
(amino acids 81–422) of SYT1 (CCSB-12023) was amplified using
the primers #32 and #33. The coding sequence of VCP lacking the
stop codon was amplified from the entry clone IOH52832 using the
primers #34 and #35. To generate the CSPa deletion mutation
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DL116 and the single point mutation L115R (Noskova´ et al, 2011),
the vector pDONR221-DNAJC5 was PCR amplified with the phos-
phorylated primers #36 and #37 (DL116) or #38 and #39 (L115R),
respectively. The PCR products were ligated and transformed into
Mach1 competent Escherichia coli cells. The DULIP expression
plasmids and the entry vectors pDONR221-mCherrry, pDONR221-
Munc18-wt, -K46E, -E59K, and -K46E/E59K were generated previ-
ously (Trepte et al, 2015).
For LuTHy experiments, all cDNAs were shuttled from the entry
vectors into the LuTHy destination vectors (pcDNA3.1 or pLenti)
using the LR clonase technology according to the manufacturer’s
instructions (Invitrogen). Similarly, for DULIP and FRET assays, the
cDNAs from the entry vectors pDONR223-RNASE1 (CCSB-5532) and
pDONR223-RNH1 (CCSB-3255) were shuttled into the destination
vectors pGW-RL-PA, pGW-FL-V5, or pDS_X-mCherry (ATCC® MBA-
303TM). The plasmid encoding the PA-mCit-mChe fusion protein was
generated by LR recombination using the pDONR221-mCherry and
pPA-mCit-GW vectors. All used primers can be found in Dataset
EV12.
Cell culture, transfection, and lentivirus preparation
The human embryonic kidney cell line 293 (HEK293) was grown in
low-glucose (1 g/l) DMEM (Gibco®, ThermoFisher) for DULIP and
FRET experiments and in high glucose (4.5 g/l) for LuTHy assays.
In both cases, media were supplemented with 10% heat inactivated
fetal bovine serum (Gibco®, ThermoFisher) and cells were grown at
37°C and 5% CO2. Cells were subcultured every 3–4 days and trans-
fected with linear polyethylenimine (25 kDa, Polysciences) using
the reverse transfection method according to the manufacturer’s
instructions. For LuTHy transfections, cells were seeded in phenol-
red-free, high-glucose DMEM media (Gibco®, ThermoFisher)
supplemented with 10% heat inactivated fetal bovine serum. Trans-
fections were performed with a total DNA amount of ~200 ng per
well in a 96-well plate. If expression plasmid concentration was
below 200 ng/well, pcDNA3.1 (+) was used as carrier DNA to
obtain the total DNA amount of 200 ng.
For LuTHy experiments in hippocampal neurons, all proce-
dures involving animals were approved by the animal welfare
committee of Charite´ Medical University and the Berlin state
government. First, hippocampi were dissected from WT mice P0-2
brains in cold Hanks’ salt solution (Millipore), followed by a 30-
min incubation in enzyme solution [DMEM (Gibco, ThermoFisher
Scientific), 3.3 mM cysteine, 2 mM CaCl2, 1 mM EDTA, 20 U/ml
papain (Worthington)] at 37°C. Papain reaction was inhibited by
the incubation of hippocampi in inhibitor solution DMEM, 10%
fetal calf serum (ThermoFisher Scientific), 38 mM BSA (Sigma-
Aldrich), and 95 mM trypsin inhibitor (Sigma-Aldrich) for 5 min.
Afterward, cells were triturated in NBA (neurobasal-A medium,
2% B27, 1% glutamax, 0.2% P/S, ThermoFisher Scientific) by
gentle pipetting up and down.
All lentiviral particles were provided by the Viral Core Facility of
the Charite´ Berlin and prepared as described previously (Lois et al,
2002). Briefly, HEK293T cells were co-transfected with 10 lg of
shuttle vector, 5 lg of helper plasmids pCMVdR8.9, and 5 lg of
pVSV.G using X-tremeGENE 9 DNA transfection reagent (Roche
Diagnostic). Virus containing cell culture supernatant was collected
after 72 h and filtered for purification. Aliquots were flash-frozen in
liquid nitrogen and stored at 80°C.
Creation of reference sets
The CCSB reference sets hPRS and hRRS were previously described
(Braun et al, 2009). The previously described affinity-based refer-
ence set (AIRS) was extended by 14 PPIs (Trepte et al, 2015), by
selecting 18 PPIs from PDBbind (Wang et al, 2004) and 53 PPIs
from the Protein-Protein Interaction Affinity Database 2.0 (Kastritis
et al, 2011). The cDNAs encoding 71, 81, and 80 protein pairs in
AIRS, hPRS, and hRRS were shuttled into LuTHy expression plas-
mids for systematic interaction testing.
LuTHy experiments
1) Reverse transfect HEK293 cells in white 96-well microtiter plates
(Greiner, 655983) at a density of 4.0–4.5 × 104 cells per well.
Plasmids encoding donor and acceptor proteins are transfected
at a 1:10 to 1:20 ratio, with 5–10 ng DNA for the donor and
100 ng for the acceptor. Primary hippocampal neurons are
plated on poly-l-lysine coated white 96-well microtiter plates
(Greiner, 655983) at a density of 1 × 104 cells per well. Infect
neurons with 5–35 ll of the viral solution (0.5–1 × 106 IU/ml)
per well 2–4 days post-plating and culture in NBA at 37°C and
5%, for a total of 13–15 days (days in vitro, DIV) before starting
measurements.
2) Measure mCitrine fluorescence 48 h after transfection in intact
cells (Ex/Em: 500 nm/530 nm).
3) Add coelenterazine-h (NanoLight, 301 or pjk, 102182) to a
final concentration of 5 lM. Incubate cells for an additional
15 min and measure the total, short-WL and long-WL lumi-
nescence. Here, fluorescence and luminescence were
measured using the Infinite® microplate readers M200,
M1000, or M1000Pro (Tecan) using the BLUE1 (370–480 nm)
and the GREEN1 (520–570 nm) filters at 1,000 ms integration
time.
4) After luminescence measurements in intact cells, the lumines-
cence-based co-precipitation (LuC) is performed. Lyse cells in
50–100 ll HEPES-phospo-lysis buffer (50 mM HEPES,
150 mM NaCl, 10% glycerol, 1% NP-40, 0.5% deoxycholate,
20 mM NaF, 1.5 mM MgCl2, 1 mM EDTA, 1 mM DTT, 1 U
Benzonase, protease inhibitor cocktail (Roche, EDTA-free),
1 mM PMSF, 25 mM glycerol-2-phosphate, 1 mM sodium
orthovanadate, 2 mM sodium pyrophosphate) for 30 min at
4°C.
5) Production of PA-mCit- and NL-tagged fusion proteins is
monitored by measuring fluorescence (mCitIN) and luci-
ferase activity (NLIN) in crude cell lysates in white, small-
volume 384-well microtiter plates (Greiner, 784074). Add
5 ll coelenterazine-h to 5 ll of cell lysates to a final
concentration of 10 lM and measure the luminescence
activity as before in a microplate reader with 100 ms inte-
gration time.
6) Coat small-volume 384-well microtiter plates (Greiner, 784074)
the day before use with sheep gamma globulin (Jackson Immuno-
Research, 013-000-002) in carbonate buffer (70 mM NaHCO3,
30 mM Na2CO3, pH 9.6) for 3 h at room temperature. Block
with 1% BSA in carbonate buffer before incubating with rabbit
anti-sheep IgGs in carbonate buffer (Jackson ImmunoResearch,
313-005-003) overnight at 4°C. Equilibrate all wells with lysis
buffer immediately before use. Do not store IgG-coated plates
longer than 24 h.
ª 2018 The Authors Molecular Systems Biology 14: e8071 | 2018 15 of 20
Philipp Trepte et al Bioluminescence-based two-hybrid mapping Molecular Systems Biology
Published online: July 11, 2018 
7) Incubate 15 ll of cell lysate for 3 h at 4°C in the IgG-coated 384-
well plates. Wash all wells three times with lysis buffer and
measure the mCitrine fluorescence (mCitOUT) as above. Finally,
15 ll of PBS buffer containing 10 lM coelenterazine-h is added
to each well and the luminescence activity (NLOUT) is measured
as described above.
LuTHy donor saturation experiments
1) For donor saturation experiments, plasmid DNAs (between 0.1
and 20.0 ng) encoding NL fusion proteins are co-transfected
with increasing amounts of plasmid DNAs encoding the PA-
mCit-tagged constructs.
2) BRET measurements are performed as described before, 72 h
after transfection using NanoGlo® (Promega) at a final concen-
tration of 1:500.
3) Calculate the fluorescence to luminescence ratio for the PA-
mCit-NL tandem construct. In this fusion protein, the stoichio-
metric ratio of mCitrine and NL is 1:1. Next, the fluorescence to
luminescence ratios for the studied interactions of interest can
be estimated by normalizing the calculated values to the value
obtained with the tandem construct.
LuTHy data analysis
The BRET and LuC ratios from in vivo BRET and ex vivo co-precipi-
tation measurements are calculated as follows:
1)
BRET ratio ¼ LWL
SWL
 Cf;
with LWL and SWL being the detected luminescence at the long
(520–570 nm) and the short (370–480 nm) wavelengths,
respectively. Cf is the correction factor for the donor bleed-
through, which is the ratio of the luminescence measured at





2) The corrected BRET (cBRET) ratio is calculated by subtracting
either the BRET ratio of control 1 (NL/PA-mCit-Y) or of control
2 (NL-X/PA-mCit) from the BRET ratio of the studied interaction
of interest (NL-X/PA-mCit-Y). The calculated BRET ratios
obtained for the controls 1 and 2 are always compared with
each other, and the higher value is used to correct the BRET
ratio of the interaction of interest (see Appendix Fig S1F).
3) For the LuC readout, the obtained luminescence precipitation
ratio (PIR) of the control protein PA-NL (PIRPA-NL) is used for
data normalization, which is calculated as follows:
PIRPANL ¼ NLOUT
3 NLIn ;
with NLOUT being the total luminescence measured after co-IP
and NLIN the luminescence measured in cell extracts directly
after lysis.
4) Subsequently, LuC ratios are calculated for all interactions of
interest and normalized to the PIRPA-NL ratio:
LuC ratio ¼ NLOUT=3NLIN
PIRPANL
:
5) Finally, a corrected LuC (cLuC) ratio is calculated by subtracting
either the LuC ratio of control 1 (NL/PA-mCit-Y) or of control 2
(NL-X/PA-mCit) from the LuC ratio of the studied interaction of
interest (NL-X/PA-mCit-Y). The calculated LuC ratios obtained
for the controls 1 and 2 are always compared with each other
and the higher value used to correct the LuC ratio of the interac-
tion of interest (see Appendix Fig S1G).
A receiver operating characteristics (ROC) curve was
obtained for PPIs of the hPRS and hRRS using corrected cBRET
and cLuC ratios. Binary interactions in all LuTHy screens
(hPRS, hRRS, AIRS, UBX-domain-containing, synaptic, non-
synaptic) were scored positive with cBRET and cLuC ratios
≥ 0.01 and ≥ 0.03, respectively. Interactions between two inte-
gral-membrane or membrane-associated proteins were scored
positive with cBRET and cLuC cutoffs ≥ 0.03 and ≥ 0.05,
respectively.
Gene ontology (GO) analysis was performed using the database
for annotation, visualization, and integrated discovery (DAVID)
(Huang et al, 2009), https://david.ncifcrf.gov.
Investigating the effects of small molecules on PPIs with LuTHy
For the investigation of the effects of small molecules on PPIs with
LuTHy, HEK293 cells were co-transfected with plasmids encoding
the proteins NL-MDM2 and PA-mCit-p53 or NL-FKBP12 and PA-
mCit-FRB in white 96-well microtiter plates (Greiner, 655983).
Increasing concentrations of Nutlin-3 (Sigma, N6287) or rapamycin
(Santa Cruz, 3504A) were added to cells 24 h after transfection.
Luminescence measurements in intact cells were performed after an
additional incubation for 6 (Nutlin-3) or 4 h (rapamycin) upon addi-
tion of 5 lM coelenterazine-h. After the measurement of BRET in
intact cells, the cells were lysed with HEPES-phospho-lysis buffer
that contained the respective concentration of compounds. Finally,
the compound effects on PPIs were assessed by LuC as described
above.
For Hsp90 inhibition, cells were transfected in a 10-cm dish using
FuGENE (Promega) according to manufacturer’s instructions. Gelda-
namycin (Selleckchem S2713) and ganetespib (Selleckchem S1159)
were added to a 384-well plate 24 h after transfection and cells
seeded on top at a density of 15,000 cells per well. BRET measure-
ments were performed in a Tecan Spark reader using filter settings
at 360–485 nm and 520–650 nm at the indicated time points by
coelenterazine-h injection. For heat shock experiments, HEK293
cells were transferred 48 h after transfection to 42°C for 6 h
followed by a recovery phase at 37°C for an additional 24 h. Control
treatment was conducted with identically transfected cells, which
were constantly kept at 37°C. BRET measurements at the depicted
time points (Appendix Fig S10D) were performed as described
above.
DULIP assay
The DULIP assay and data analysis were performed as described
before (Trepte et al, 2015). Briefly, HEK293 cells were reversely
transfected and lysed after 48 h. Production of PA-RL- and FL-
tagged fusion proteins was monitored by measuring the respective
luciferase activities in crude cell lysates. In parallel, cell lysates
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were incubated for 3 h at 4°C in IgG-coated 384-well plates.
Measurement of firefly and Renilla luminescence activities was
performed using an Infinite® M1000 (Tecan) plate reader and the
Dual-Glo® Stop & Glow® reagents (Promega). NIR and cNIR
values were determined as described previously (Trepte et al,
2015).
FRET assay
FRET assays were performed as described before (Trepte et al,
2015). Briefly, HEK293 cells were reversely transfected using
100 ng plasmid DNAs encoding PA-mCitrine- and mCherry-tagged
fusion proteins in black 96-well microtiter plates at a density of
4.5 × 104 cells per well. 72 h after transfection, cells were fixed
with 4% paraformaldehyde in PBS and washed twice with PBS.
Fluorescence signals were detected with an Infinite® M1000Pro
(Tecan) plate reader: donor channel [excitation (Ex)/emission
(Em): 500/530 nm], acceptor channel (Ex/Em: 580/610 nm) and
FRET channel (Ex/Em: 500/610 nm). In brief, FRET efficiencies
(EAapp in %) were calculated according to the sensitized emission
formula as follows:
EAapp ¼ ðDA cD  DD cA  AAÞ
AA
;
with DD = donor channel signal; AA = acceptor channel signal;
DA = FRET channel signal; cD = donor bleed-through using donor
only sample (pPA-mCit); cA = acceptor cross-excitation using
acceptor only sample (pmCherry).
Western blotting
For Western blotting experiments, cells were lysed for 30 min at 4°C
in HEPES-phospho-lysis buffer and the protein concentrations deter-
mined using the PierceTM BCA assay (Thermo Scientific). Then, the
same amounts of protein lysates were loaded onto NuPAGETM
NovexTM 4–12% Bis-Tris precast polyacrylamide gels (Thermo-
Fisher) according to the manufacturer’s instructions. Following,
proteins were transferred onto a nitrocellulose membrane (GE,
10401197) using a BioRad® wet blotting system. The membrane
was blocked in 3%-milk PBS-T (phosphate-buffered saline, 0.05%
Tween) for 60 min at room temperature and incubated with primary
antibody in 3%-milk PBS-T overnight at 4°C. Bound antibodies were
detected with an appropriate HRP (horse-radish-peroxidase)-
coupled secondary anti-rabbit (1:2,000, Sigma A0545) and anti-
mouse (1:2,000, Sigma A0168) antibody by measuring chemilumi-
nescence in a Fujifilm LAS-3000 after the addition of WesternBright
Quantum (Advansta, 12042-D20). The primary antibodies used were
as follows: anti-NanoLuc (rabbit, 1:5,000, kindly provided by
Promega), anti-GFP (rabbit, 1:5,000, abcam ab290), anti-CSP (rab-
bit, 1:1,000, Synaptic Systems, 154 003), anti-Histone H3 (rabbit,
1:5,000, abcam ab1791), anti-VCP (mouse, 1:1,000, Progen, 65278),
anti-UBXD9 (rabbit, 1:1,000, LifeSpan Biosciences, LS-C156546,
EPR8616), and anti-tubulin (mouse, 1:4,000, Sigma, T6074).
Bioluminescence imaging (BLI)
HEK293 cells were seeded at a low density with 3 × 104 cells per
well in an ibidi® l-Slide 8-well tissue culture dish and transfected
using X-tremeGENE (Roche®) according to the manufacturer’s
instructions. Forty-eight hours after transfection, imaging was
performed using an Olympus® inverted microscope IX83 with an
Andor Zyla camera and a 60× objective. A Dual-ViewTM adapter
(Optical Insights®) between microscope und camera was equipped
with a short (460/50, Chroma®) and long (535/50, Chroma®) wave-
length filter. Imaging was performed in tyrode’s buffer (100 mM
NaCl, 5 mM KCl, 2 mM HEPES, 2 mM CaCl2, 4 mM MgCl2, 33 mM
glucose) containing 1:50 NanoGlo® (Promega) substrate. Before
substrate addition, mCitrine was excited with a LED excitation
system (CoolLED® pE, 2%) using a YFP-excitation filter (Olympus®,
AHF F48-003 ET-Set); the emitted fluorescence was detected with an
exposure time of 100 ms. Bioluminescence imaging started immedi-
ately after substrate addition with an exposure time of 3,000 ms.
Images were processed with ImageJ (http://imagej.nih.gov/ij/).
Fluorescence images were background-corrected with the contrast
adjusted for each image individually as the fluorescence signal was
only used to study the localization of mCit-tagged proteins. The
bioluminescence images, which contain the short (460 BP) and long
wavelength (530 BP) signals, were split into two separate images.
These two images were stacked and aligned using the StackReg
plugin in ImageJ (The´venaz, 1998). Next, the images were
smoothed by median filtering, background-subtracted, and thresh-
olded on luminescence intensities. To calculate the BRET ratio on a
pixel-by-pixel basis, the 530 BP image was divided by the 460 BP
image using the image calculator and presented in pseudo-color for
better visualization.
Proximity ligation assay
All animals were sacrificed according to the permit given by the
Office for Health Protection and Technical Safety of the regional
government of Berlin (LaGeSo, X9009/14) and in compliance with
regulations laid down in the European Community Council Direc-
tive. One day before preparation of primary neurons, all coverslips
containing culture plates were coated with poly-DL ornithine hydro-
bromide (PO, 0.005% PO in H2O) over night at 37°C. On the prepa-
ration day, the coating solution was removed and plates were
incubated with DMEM containing 10% FCS for several hours. The
pregnant mice were sacrificed by cervical dislocation and the
embryos were removed and placed in ice-cold standard salt solution
(SSS, 135 mM NaCl, 5 mM KCl, 1.25 mM CaCl2, 0.5 mM MgCl2,
0.5 mM MgSO4, 1 mM NaHCO3, 10 mM HEPES, 25 mM glucose, 1×
AB/AM). Brains of all embryos were isolated and collected in SSS
on ice. Next, the meninges were removed and hippocampi of all
embryos were isolated. The tissue was cut in smaller pieces and
treated with trypsin solution (1× PBS-CMF, 20 mM glucose, 15 mM
HEPES, 1× AB/AM, EDTA 1 mM, 3,428 BAEE/ml trypsin) for 5 min
at 37°C. The reaction was stopped using DNase-Ovomucoid solution
(Hanks MEM, 0.44 mM MgCl2, 25 mM HEPES, 20 mM glucose,
50 mM MgSO4, 30 mg/ml trypsin inhibitor, DNase 1,380 U/ml). The
tissue was triturated step wise to generate a single cell suspension.
The cells were counted and plated in 24-well plates containing glass
coverslips at an initial density of 68.000/cm2. The hippocampal
cultures were maintained in B27- and 1% FCS-supplemented neuro-
basal medium (neurobasal medium, 25 lM b-mercaptoethanol,
0.25 mM L-glutamine, 2% B27-supplement, 0.05% penicillin/
streptomycin, 1% FCS). On day in vitro (DIV) 4, cells were treated
with AraC (5 lM) to eliminate glia cells from the culture. Neurons
were fixed on cover slips at 14 DIV using 4% PFA in PBS for
15 min, followed by fixation in methanol fix (100 mM MES, pH
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6.9, 1 mM EGTA, 1 mM MgCl2, 90% MeOH). Following, cells were
blocked in 0.1% saponin (Sigma-Aldrich), 1% BSA (VWR), 4%
goat serum (Dako), 50 ng/ll RNase A (Promega), 11 ng/ll poly
(A) (P9403 Sigma-Aldrich), and 2.5 ng/ll salmon sperm DNA
(Invitrogen) in PBS for 30 min at room temperature. Proximity
ligation assays (PLAs) were performed according to manufacturer’s
protocol (Duolink® In Situ Detection Reagents Orange, Sigma-
Aldrich). Primary antibodies were prepared in antibody diluent
PBS containing (0.1% saponin, 3% BSA, and 1:1,000 salmon
sperm DNA) and incubated with slides (50 ll/sample) for 1 h at
37°C in a humidity chamber. Unbound primary antibodies were
removed by washing the slides 3× in PBS with 0.1% saponin.
Thereafter, both PLA probes (Duolink® Anti-Rabbit PLUS and Anti-
Mouse MINUS) were diluted 1:5 in antibody diluent and allowed
to sit for 20 min before being added to cover slips (40 ll/sample)
for 1 h at 37°C in a humidity chamber. Slides were washed for
2 × 5 min in wash buffer A (0.01 M Tris, 0.15 M NaCl, 0.05%
Tween) under gentle agitation to remove unbound PLA probes.
For the ligation, cover slips were incubated with Duolink® ligation
reagent (Ligation stock 1:5 in antibody diluent plus ligase, 1:40;
40 ll/sample) for 30 min at 37°C in a humidity chamber. Washing
was performed 2 × 2 min with wash buffer A under gentle agita-
tion. For signal amplification, Duolink® Amplification stock was
diluted 1:5 in high-purity water and polymerase (1:80) was added
before slides were incubated (40 ll/sample) for 100 min at 37°C
in a humidity chamber. Final washing steps were performed with
2 × 10 min 1× wash buffer B (0.2 M Tris, 0.1 M NaCl) and
1 × 1 min 0.01× wash buffer B. Coverslips were mounted in fluo-
rescent mount medium (Dako) and images acquired on a Leica
TCS SP5 confocal microscope in the Advanced Light Microscopy
(ALM) technology platform at the Max Delbru¨ck Center for Molec-
ular Medicine. Images were processed with ImageJ.
The primary antibodies used were as follows: anti-CSPa (rabbit,
1:100, Synaptic Systems, 154003), anti-VGLUT1/SLC17A7 (mouse,
1:250, Synaptic Systems, 135311), anti-VGAT/SLC32A1 (mouse,
1:200, Synaptic Systems, 131011), anti-STX4 (mouse, 1:100, Synap-
tic Systems, 110 041), anti-SYP (mouse, 1:100, Sigma, SVP-38), anti-
SYT1 (mouse, 1:50, SantaCruz, sc-135574), anti-VAMP2 (mouse,
1:250, Synaptic Systems, 104211), and IgG isotype control (mouse,
1:2,500, ThermoFisher, 02-6502).
Immunofluorescence imaging
SHEP cells (Muth et al, 2010) were seeded at low density
(3 × 105 cells) onto fibronectin (10 lg/ml)-coated coverslips in a 6-
well plate and transfected using GeneJetTM (SignaGen, SL100488)
according to the manufacturer’s instructions. Forty-eight hours after
transfection, the cells were fixed with 4% paraformaldehyde in PBS
with 1:5,000 Hoechst (ThermoFisher, 33342). Cells were permeabi-
lized with 0.1% saponin in PBS for 10 min and blocked with 3%
BSA, 0.1% saponin in PBS for 30 min at RT. Primary anti-NanoLuc
(rabbit, 1:1,000, Promega) and secondary Cy5-coupled anti-rabbit
(1:500) antibodies were diluted in 3% BSA, 0.1% saponin in PBS
and applied successively to the coverslips for 1 h at 37°C with three
washing steps in between. Coverslips were mounted in fluorescent
mount medium (Dako) and images acquired on a Leica TCS SP5
confocal microscope in the Advanced Light Microscopy (ALM) tech-
nology platform at the Max Delbru¨ck Center for Molecular Medicine.
Images were processed with ImageJ.
Data availability
The protein interactions from this publication have been submit-
ted to the IMEx (http://www.imexconsortium.org) consortium
through IntAct (Orchard et al, 2014) and assigned the identifier
IM-26441.
Expanded View for this article is available online.
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